Multi-organ quantitative MRI for the assessment of liver disease – A whole much more than the sum of its parts
Author(s): ,
Rajeshwar P. Mookerjee
University College London (UCL) Institute for Liver and Digestive Health, Division of Medicine, UCL, London, UK
Stuart A. Taylor
University College London (UCL) Centre for Medical Imaging, Division of Medicine, UCL, London, UK
Manil D. Chouhan
University College London (UCL) Centre for Medical Imaging, Division of Medicine, UCL, London, UK
Corresponding author. Address: UCL Centre for Medical Imaging, University College London, 3rd Floor East, 250 Euston Road, London NW1 2PG, UK. Tel.: +44 0203 447 9324.
EASL LiverTree™. Chouhan M. 11/01/18; 256695
Manil D. Chouhan
Manil D. Chouhan
Journal Abstract
This article does not have an abstract to display.
[1]. M.D. Chouhan - Multiparametric magnetic resonance imaging to predict clinical outcomes in patients with chronic liver disease: a cautionary note on a promising technique
[2]. T.J. Bray - Fat fraction mapping using magnetic resonance imaging: insight into pathophysiology
[3]. T. Yokoo - Fat and iron quantification in the liver
[4]. M.D. Chouhan - Vascular assessment of liver disease-towards a new frontier in MRI
[5]. C.R. Bradley - Multi organ assessment of compensated cirrhosis patients using quantitative magnetic resonance imaging
[6]. S. Agrawal - Visual morphometry and three non-invasive markers in the evaluation of liver fibrosis in chronic liver disease
[7]. E.H. Wissler - Identifying a long standing error in single-bolus determination of the hepatic extraction ratio for indocyanine green
[8]. M.D. Chouhan - Use of caval subtraction 2D phase-contrast mr imaging to measure total liver and hepatic arterial blood flow: preclinical validation and initial clinical translation
[9]. C.L. Hoad - A study of T relaxation time as a measure of liver fibrosis and the influence of confounding histological factors
[10]. Chouhan MD, Ramasawmy R, Bainbridge A, Campbell-washburn A, Wells J, Punwani S, et al. Measurement of bulk liver perfusion: Assessment of agreement between ASL and caval subtraction phase-contrast MRI at 9.4T. Proc. Intl. Soc. Mag. Reson. Med., Singapore: 2016, p. 0162.
[11]. N. Palaniyappan - Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging
[12]. K.S. Lee - Corticomedullary differentiation on T1-Weighted MRI: comparison between cirrhotic and noncirrhotic patients
[13]. M. Chouhan - Phase contrast and cardiac cine MRI for non-invasive assessment of hepatic haemodynamic and cardiac systolic function in a rodent model of chronic liver disease
[14]. S. Wiese - Cirrhotic cardiomyopathy: pathogenesis and clinical relevance
[15]. T. Sersté - Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites
[16]. F.E. Mozes - Influence of fat on liver T measurements using modified Look-Locker inversion recovery (MOLLI) methods at 3T
[17]. X. Pan - Quantification of liver perfusion using multidelay pseudocontinuous arterial spin labeling
[18]. M.D. Chouhan - Caval subtraction 2D phase-contrast MRI to measure total liver and hepatic arterial blood flow
[19]. N.C. McAvoy - Differential visceral blood flow in the hyperdynamic circulation of patients with liver cirrhosis
[20]. N. McDonald - Assessment of haemodynamic response to nonselective beta-blockers in portal hypertension by phase-contrast magnetic resonance angiography
[21]. V.K. Snowdon - Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies